<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Becerro-Recio D</submitter><funding>Ministerio de Ciencia, Innovación y Universidades</funding><funding>Consejería de Educación, Junta de Castilla y León</funding><funding>Ministerio de Ciencia e Innovación</funding><funding>Ministerio de Economía, Industria y Competitividad, Gobierno de España</funding><pagination>e0010766</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9518905</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(9)</volume><pubmed_abstract>Fasciola hepatica is a trematode parasite that infects animals and humans causing fasciolosis, a worldwide-distributed disease responsible for important economic losses and health problems. This disease is of growing public health concern since parasite isolates resistant to the current treatment (triclabendazole) have increasingly been described. F. hepatica infects its vertebrate host after ingestion of the encysted parasite (metacercariae), which are found in the water or attached to plants. Upon ingestion, newly excysted juveniles of F. hepatica (FhNEJ) emerge in the intestinal lumen and cross the intestinal barrier, reach the peritoneum and migrate to the biliary ducts, where adult worms fully develop. Despite the efforts made to develop new therapeutic and preventive tools, to date, </pubmed_abstract><journal>PLoS neglected tropical diseases</journal><pubmed_title>Study of the migration of Fasciola hepatica juveniles across the intestinal barrier of the host by quantitative proteomics in an ex vivo model.</pubmed_title><pmcid>PMC9518905</pmcid><funding_grant_id>Predoctoral contract</funding_grant_id><funding_grant_id>RTI2018-093463-J-100</funding_grant_id><funding_grant_id>Projects AGL2015-67023-C2-2-R and AGL2015-67023-C2-1-R</funding_grant_id><funding_grant_id>Juan de la Cierva Incorporación</funding_grant_id><funding_grant_id>FPU predoctoral contract</funding_grant_id><funding_grant_id>Projects PID2019-108782RB-C22 and PID2019-108782RB-C21</funding_grant_id><funding_grant_id>CLU-2019-05 – IRNASA/CSIC Unit of Excellence</funding_grant_id><pubmed_authors>Siles-Lucas M</pubmed_authors><pubmed_authors>Lopez-Garcia M</pubmed_authors><pubmed_authors>Perez-Arevalo J</pubmed_authors><pubmed_authors>Becerro-Recio D</pubmed_authors><pubmed_authors>Simon F</pubmed_authors><pubmed_authors>Molina-Hernandez V</pubmed_authors><pubmed_authors>Martinez-Moreno A</pubmed_authors><pubmed_authors>Serrat J</pubmed_authors><pubmed_authors>Sotillo J</pubmed_authors><pubmed_authors>Gonzalez-Miguel J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Study of the migration of Fasciola hepatica juveniles across the intestinal barrier of the host by quantitative proteomics in an ex vivo model.</name><description>Fasciola hepatica is a trematode parasite that infects animals and humans causing fasciolosis, a worldwide-distributed disease responsible for important economic losses and health problems. This disease is of growing public health concern since parasite isolates resistant to the current treatment (triclabendazole) have increasingly been described. F. hepatica infects its vertebrate host after ingestion of the encysted parasite (metacercariae), which are found in the water or attached to plants. Upon ingestion, newly excysted juveniles of F. hepatica (FhNEJ) emerge in the intestinal lumen and cross the intestinal barrier, reach the peritoneum and migrate to the biliary ducts, where adult worms fully develop. Despite the efforts made to develop new therapeutic and preventive tools, to date, </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2026-04-08T11:55:10.565Z</modification><creation>2025-02-19T02:24:42.32Z</creation></dates><accession>S-EPMC9518905</accession><cross_references><pubmed>36112664</pubmed><doi>10.1371/journal.pntd.0010766</doi></cross_references></HashMap>